Pérez-Islas E, García-Carrancá A, Acosta-Gio E, Reynoso-Noverón N, Maldonado-Martínez HA, Guido-Jiménez M, et al. Prognostic importance of DNA from human papillomavirus in patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2022 Mar 1;27 (2):e150-8.
doi:10.4317/medoral.25092
https://dx.doi.org/doi:10.4317/medoral.25092
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. |
PMid:30207593 |
2. Polesel J, Lupato V, Collarile P, Vaccher E, Fanetti G, Giacomarra V, et al. Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy. Med Oncol. 2019;36:31. |
PMid:30815763 |
3. Le Campion A, Ribeiro CMB, Luiz RR, da Silva Junior FF, Barros HCS, Dos Santos KCB, et al. Low Survival Rates of Oral and Oropharyngeal Squamous Cell Carcinoma. Int J Dent. 2017;2017:5815493. |
PMid:28638410 PMCid:PMC5468590 |
4. Wang W, Adeoye J, Thomson P, Choi SW. Statistical profiling of oral cancer and the prediction of outcome. J Oral Pathol Med. 2021;50:39-46. |
PMid:32939835 |
5. Brockstein BE. Management of recurrent head and neck cancer: Recent progress and future directions. Drugs. 2011;71:1551-9. |
PMid:21861540 |
6. Kibe Y, Nakamura N, Kuno H, Hiyama T, Hayashi R, Zenda S, et al. Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy. Int J Clin Oncol. 2019;24:1182-9. |
PMid:31289957 |
7. Diao P, Wu Y, Ge H, Li J, Zhang W, Huang R, et al. Preoperative circulating platelet, neutrophil, and lymphocyte counts predict survival in oral cancer. Oral Dis. 2019;25:1057-66. |
PMid:30697882 |
8. Kargus S, Weber FE, Luebbers HT, Zemann W, Graetz KW, Kruse AL. Pretreatment thrombocytosis: A prognostic marker for oral squamous cell carcinoma?. Oral Maxillofac Surg. 2012;16:197-200. |
PMid:22108700 |
9. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004;10:3755-62. |
PMid:15173082 |
10. Li H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA Otolaryngol Head Neck Surg. 2018;144:519-25. |
PMid:29801040 PMCid:PMC6583856 |
11. Sahovaler A, Kim MH, Mendez A, Palma D, Fung K, Yoo J, et al. Survival Outcomes in Human Papillomavirus-Associated Nonoropharyngeal Squamous Cell Carcinomas: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2020;146:1158-66. |
PMid:33057610 PMCid:PMC7563675 |
12. Kelly JR, Husain ZA, Burtness B. Treatment de-intensification strategies for head and neck cancer. Eur J Cancer. 2016;68:125-33. |
PMid:27755996 PMCid:PMC5734050 |
13. Biesaga B, Janecka A, Mucha-Malecka A, Adamczyk A, Szostek S, Slonina D, et al. HPV16 detection by qPCR method in relation to quantity and quality of DNA extracted from archival formalin fixed and paraffin embedded head and neck cancer tissues by three commercially available kits. J Virol Methods. 2016;236:157-63. |
PMid:27456982 |
14. Micalessi MI, Boulet GA, Vorsters A, De Wit K, Jannes G, Mijs W, et al. A real-time PCR approach based on SPF10 primers and the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus. J Virol Methods. 2013;187:166-71. |
PMid:23018060 |
15. Rivelli V, Luebbers HT, Weber FE, Cordella C, Grätz KW, Kruse AL. Screening recurrence and lymph node metastases in head and neck cancer: the role of computer tomography in follow-up. Head Neck Oncol. 2011;3:18. |
PMid:21439046 PMCid:PMC3079696 |
16. Castellsague X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX, et al. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study. J Med Virol. 2012;84:947-56. |
PMid:22499018 |
17. Kovanda A, Juvan U, Sterbenc A, Kocjan BJ, Seme K, Jancar N, et al. Pre-vaccination distribution of human papillomavirus (HPV) genotypes in women with cervical intraepithelial neoplasia grade 3 (CIN 3) lesions in Slovenia. Acta Dermatovenerol Alp Pannonica Adriat. 2009;18:47-52. |
PMid:19588057 |
18. Belobrov S, Cornall AM, Young RJ, Koo K, Angel C, Wiesenfeld D, et al. The role of human papillomavirus in p16-positive oral cancers. J Oral Pathol Med. 2018;47:18-24. |
PMid:29024035 |
19. Lechner M, Chakravarthy AR, Walter V, Masterson L, Feber A, Jay A, et al. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer. Oral Oncol.2018;83:32-7. |
PMid:30098776 |
20. Ziai H, Warner A, Mundi N, Patel K, Chung EJ, Howlett CJ, et al. Does HPV Subtype Predict Outcomes in Head and Neck Cancers?. Int J Otolaryngol. 2021;2021:1-11. |
PMid:33824664 PMCid:PMC8006754 |
21. de Ridder M, de Veij Mestdagh PD, Elbers JBW, Navran A, Zuur CL, Smeele LE, et al. Disease course after the first recurrence of head and neck squamous cell carcinoma following (chemo)radiation. Eur Arch Oto-Rhino-Laryngology. 2020;277:261-8. |
PMid:31602525 |
22. Ho WJ, Yarchoan M, Hopkins A, Mehra R, Grossman S, Kang H. Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas. J Immunother Cancer. 2018;6:84. |
PMid:30170629 PMCid:PMC6117944 |
23. Lin AJ, Gang M, Rao YJ, Campian J, Daly M, Gay H, et al. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers. JAMA Otolaryngol Head Neck Surg. 2019;145:413-21. |
PMid:30920592 PMCid:PMC6537794 |
24. Hottz ED, Bozza FA, Bozza PT. Platelets in Immune Response to Virus and Immunopathology of Viral Infections. Front Med. 2018;5:121. |
PMid:29761104 PMCid:PMC5936789 |
25. Park JW, Kim CH, Ha YC, Kim MY, Park SM. Count of platelet and mean platelet volume score: serologic prognostic factor in patients with oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg. 2017;43:305-11. |
PMid:29142864 PMCid:PMC5685859 |
26. Steinbichler TB, Lichtenecker M, Anegg M, Dejaco D, Kofler B, Schartinger VH, et al. Persistent head and neck cancer following first-line treatment. Cancers (Basel). 2018;10:421. |
PMid:30400290 PMCid:PMC6265977 |
27. Gaitán-Cepeda LA, Peniche-Becerra AG, Quezada-Rivera D. Trends in frequency and prevalence of oral cancer and oral squamous cell carcinoma in Mexicans. A 20 years retrospective study. Med Oral Patol Oral Cir Bucal. 2011;16:e1-5. |
PMid:20711111 |
28. Monteiro LS, do Amaral JB, Vizcaíno JR, Lopes CA, Torres FO. A clinical-pathological and survival study of oral squamous cell carcinomas from a population of the north of Portugal. Med Oral Patol Oral Cir Bucal. 2014;19:120-6. |
PMid:24121907 PMCid:PMC4015041 |
29. Benson E, Li R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol. 2014;50:565-74. |
PMid:24134947 PMCid:PMC4391706 |